SHARE

Newmark Security PLC (LON:NWT) has announced two new customer wins for its Human Capital Management (HCM) division in the United States, branded GT Clocks. The US business has landed a deal for its GT-4 timeclock product with one new client, a healthcare management firm which provides human resources and payroll solutions that works with more than 30,000 businesses. It is a three-year contract and has a minimum value of US$1mln over that period. The other contract win is with an existing customer to provide the company's flagship device, the GT-10, to one of the largest retailers in the US. Newmark estimates it could potentially worth US$3.8mln over the next 2-3 years.

Adamas Finance Asia Limited (LON:ADAM) said portfolio company, Future Metal Holdings Limited successfully completed its Mining Licence renewal on August 6, 2020, after securing all necessary approvals from the local Ministry of Natural Resources in China. The renewed Mining Licence has a validity period of three years and permits a maximum annual dolomite production capacity of 300,000 tonnes, the group noted. FMHL is a natural resources company which operates an open-pit dolomite quarry in Shanxi Province, China.

i3 Energy PLC (LON:i3E) has revealed a quick-flip of recently-acquired Canadian oil and gas assets and a new £30mln funding via a share sale. A month ago I3E agreed the reverse takeover of Gain Energy, a producer in the Western Canadian Sedimentary Basin, via a C$80mln (US$59mln) deal and today it announced a follow-on deal to sell the Gain assets located in Saskatchewan for C$45mln (US$33mln). It will sell the asset package to Harvard Resources Inc immediately following completion of the reverse takeover. The company noted that the transaction means that the net consideration to acquire Gain drops to C$35mln (US$26mln). To raise £30mln, I3E is issuing new shares priced at 5p each which is a discount of around 18% to the price prior to the shares temporary suspension on AIM. In a separate statement, I3E reported financial results for the year to December 31, 2019, a year which included fundings grossing £24.4mln, the closure of around £22mln of investment by Bybrook Capital, BP, Lombard Odier and James Caird Asset Management.

SIMEC Atlantis Energy Limited (LON:SAE) said it has now signed a heads of terms agreement in relation to the joint venture (JV) it announced yesterday. The JV, NPA Fuels Limited, is with N&P Holding 2 Ltd, a wholly-owned subsidiary of the Dutch recycling specialists, the N+P Group. The NPA JV will principally be involved in the marketing, production and delivery of waste-derived fuel pellets to converted coalfired power stations throughout the UK, and in particular the Uskmouth project.

IQ-AI Ltd (LON:IQAI), the neuroimaging specialist, has said treatment priorities are returning to something approaching normal following the disruption caused by the coronavirus (COVID-19) pandemic. “The company has entered an exciting phase in its development, and we look forward to updating shareholders as events unfold,” Trevor Brown, the companys chief executive told investors in IQ-AI's half-year report. Despite the challenges presented by the COVID-19 pandemic, the company maintained its momentum in the first half of 2020. It said the most notable feature of the half-year was the artificial intelligence development work underway to fully automate the processing and display of its subsidiary, Imaging Biometrics (IB) quantitative biomarkers for brain tumour assessment.

OKYO Limited (LON:OKYO), which is developing treatments for dry eye disease and chronic pain, has appointed one of Americas leading eye surgeons to head its scientific advisory board. He is Dr A James Khodabakhsh, the medical director of the Beverly Hills Institute of Ophthalmology and chief of ophthalmology at the Cedars Sinai Medical Centre. His remit is to bring together a small group of leaders in the field to “review and inform” the companys plans to progress its lead product candidate, Chemerin, to the investigational new drug stage for dry-eye disease.

Columbus Energy Resources PLC (LON:CERP) shares have been temporarily suspended from AIM ahead of its planned merger with Bahamas Petroleum PLC (LON:BPC). Bahamas struck a £25mln deal to acquire fellow Caribbean and South America focussed oil junior Columbus in June, a combination it said will create a “Caribbean and Atlantic margin focused oil and gas champion”.

SDX Energy PLC (LON:SDX), the MENA-focused oil and gas company, has announced that as a result of Cantor Fitzgerald Europe closing certain elements of its corporate finance function, its corporate brokers are now Stifel Nicolaus Europe Limited and Peel Hunt LLP. The company's Nominated Adviser will continue to be Stifel Nicolaus Europe Limited.

Feedback PLC (LON:FDBK), the specialist medical imaging technology company, announced that it has granted options over 13,498,748 new ordinary shares, representing 1.27% of the company's issued share capital, to its CEO, Tom Oakley. The CEO Options are exercisable at a price of 1.2p at any time up to the tenth anniversary of the date of grant. One-third of the CEO Options vest immediately, one-third will vest one year from date of grant and the balance will vest two years from the date of the grant. Oakley now hold options over 22,820,829 Feedback ordinary shares, equivalent to 2.14 % of the company's voting rights. In total 60,330,829 options are now outstanding, representing approximately 5.65% of the company's current issued share capital.

APQ Global Limited (LON:APQ), an emerging markets growth company based in Guernsey, said it has issued a total of 26,578 ordinary shares of no par value in the capital of the company to employees as part of the 2018 management share-based compensation scheme, including to its chief executive officer, Bart Turtelboom, who has received 23,366 ordinary shares. The price used in calculating the number of shares awarded under the 2018 Scheme was the book value per share as at December 31, 2017, of 128.11 US cents. Following this issue, Turtelboom is interested in 22,238,659 ordinary shares in the company representing 28.39% of the issued share capital.

Coinsilium Group Limited (AQSE:COIN) the Blockchain, DeFi and Crypto Finance venture operator, has announced the release of a new investor presentation covering its recently announced DeFi Strategy, together with further details of the company's operational activities in the sector. A Pdf version of this presentation entitled 'The New Crypto Finance Opportunity' can be downloaded from the Coinsilium website via the following link: https://coinsilium.com/investors/presentations. To accompany the presentation, a video run-through hosted by Coinsilium's chairman Malcolm Palle and chief executive Eddy Travia is available for investors. The video is available in full on YouTube via the following link: https://youtu.be/IZkOwjZ9MU4. Palle commented: "With the forthcoming launch of our new DeFi Strategy we are now moving into a period of intense activity. Investor awareness and engagement is of critical importance in this process as we work to ensure a greater understanding of the scale of the opportunity that lies ahead for Coinsilium and where the Company is positioned with its global partner network at the forefront of this exciting new space. We will continue to build our investor engagement throughout this period with enhanced marketing & communications initiatives and we look forward to providing further updates to the market over the coming weeks and month."

Amryt Pharma PLC (LON:AMYT) (NASDAQ:AMYT), a global, commercial-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from serious and life-threatening rare diseases, has announced that it will present at the Canaccord Genuity Virtual 40th Annual Growth Conference on August 13, 2020. The presentation will be broadcast live at 3pm (ET) / 8pm (BST). Investors can access the webcast via the following link: LON:NWT) has announced two new customer wins for its Human Capital Management (HCM) division in the United States, branded GT Clocks. The US business has landed a deal for its GT-4 timeclock product with one new client, a healthcare management firm which provides human resources and payroll solutions that works with more than 30,000 businesses. It is a three-year contract and has a minimum value of US$1mln over that period. The other contract win is with an existing customer to provide the company's flagship device, the GT-10, to one of the largest retailers in the US. Newmark estimates it could potentially worth US$3.8mln over the next 2-3 years. Adamas Finance Asia Limited (LON:ADAM) said portfolio company, Future Metal Holdings Limited successfully completed its Mining Licence renewal on August 6, 2020, after securing all necessary approvals from the local Ministry of Natural Resources in China. The renewed Mining Licence has a validity period of three years and permits a maximum annual dolomite production capacity of 300,000 tonnes, the group noted. FMHL is a natural resources company which operates an open-pit dolomite quarry in Shanxi Province, China. SIMEC Atlantis Energy Limited (LON:SAE) said it has now signed a heads of terms agreement in relation to the joint venture (JV) it announced yesterday. The JV, NPA Fuels Limited, is with N&P Holding 2 Ltd, a wholly-owned subsidiary of the Dutch recycling specialists, the N+P Group. The NPA JV will principally be involved in the marketing, production and delivery of waste-derived fuel pellets to converted coalfired power stations throughout the UK, and in particular the Uskmouth project. IQ-AI Ltd (LON:IQAI), the neuroimaging specialist, has said treatment priorities are returning to something approaching normal following the disruption caused by the coronavirus (COVID-19) pandemic. “The company has entered an exciting phase in its development, and we look forward to updating shareholders as events unfold,” Trevor Brown, the companys chief executive told investors in IQ-AI's half-year report. Despite the challenges presented by the COVID-19 pandemic, the company maintained its momentum in the first half of 2020. It said the most notable feature of the half-year was the artificial intelligence development work underway to fully automate the processing and display of its subsidiary, Imaging Biometrics (IB) quantitative biomarkers for brain tumour assessment. OKYO Limited (LON:OKYO), which is developing treatments for dry eye disease and chronic pain, has appointed one of Americas leading eye surgeons to head its scientific advisory board. He is Dr A James Khodabakhsh, the medical director of the Beverly Hills Institute of Ophthalmology and chief of ophthalmology at the Cedars Sinai Medical Centre. His remit is to bring together a small group of leaders in the field to “revRead More – Source